Literature DB >> 2497195

Products of stimulated monocytes enhance the activity of interferon-gamma.

T L Gerrard1, D R Dyer, J C Enterline, K C Zoon.   

Abstract

We have investigated the interaction of interferon-gamma (IFN-gamma) with monocytes or products of stimulated monocytes. We have shown that IFN-gamma does not stimulate IFN-alpha production in monocytes. Staphylococcus aureus (SAC) but not lipopolysaccharide (LPS) induced IFN-alpha secretion by monocytes. However, it was observed that supernatants of monocytes stimulated with IFN-gamma in combination with either LPS or SAC had higher levels of antiviral activity than supernatants of monocytes stimulated only with IFN-gamma. Moreover, the degree of enhancement of antiviral activity was dependent on the dose of either LPS or SAC used to stimulate the monocytes. Supernatants of monocytes stimulated with LPS or SAC enhanced the antiviral activity of IFN-gamma but not IFN-alpha. Thus, LPS- or SAC-stimulated monocytes produced a factor(s) that augmented the biological activity of IFN-gamma. To identify the factor within stimulated monocyte supernatants that was responsible for this enhancement, several monokines were added to IFN-gamma. Tumor necrosis factor (TNF) significantly increased the antiviral activity of IFN-gamma, although TNF by itself had no antiviral activity. Interleukin 1 (IL-1) or granulocyte-monocyte colony-stimulating factor (GM-CSF) did not enhance the activity of IFN-gamma. Our data indicate that the interaction between IFN-gamma and monocytes is bidirectional. Not only can IFN-gamma activate monocytes, but products of stimulated monocytes also enhance the biological activities of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497195     DOI: 10.1089/jir.1989.9.115

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  1 in total

1.  Mechanisms of LPS-induced CD40 expression in human peripheral blood monocytic cells.

Authors:  Weidong Wu; Neil E Alexis; Philip A Bromberg; Ilona Jaspers; David B Peden
Journal:  Biochem Biophys Res Commun       Date:  2008-12-30       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.